TechConnect World 2018
Co-Located with Nanotech 2018 SBIR/STTR Spring Defense TechConnect
Nanotech 2018

Cancer Nanotechnology

Cancer Nanotechnology

Sponsored by:
NanoMedicines Alliance

Abstracts Due: January 19, 2018

Symposium Co-Chairs

Mansoor M.  AmijiMansoor M. Amiji
Distinguished Professor & Chair, Dept. of Pharmaceutical Sciences, Co-Director, Nanomedicine Education & Research Consortium
Northeastern University

Anil  PatriAnil Patri
Director, NCTR/ORA NanoCore, National Center for Toxicological Research
U.S. Food and Drug Administration

Key Speakers

Sanyogitta PuriSanyogitta Puri
Associate Principle Scientist
AstraZeneca, United Kingdom

Mark E. DavisMark E. Davis
Warren and Katharine Schlinger Professor of Chemical Engineering
California Institute of Technology

Frank  Szokaiposome Encapsulation of Sparingly Soluble Agents Enables Novel Drug Combinations to Treat Cancer
Frank Szoka
Co-Founder, Chairman of the Board, ZoneOne Pharma

This symposium will highlight the ways in which nanotechnology can address challenges of cancer detection, diagnosis and therapy. Distinguished speakers will summarize the current state of the art and share the excitement surrounding approaches and materials that will have a revolutionary impact on cancer treatment in the future. Contributions are also solicited in the following topics:

Submit Your Abstract

Please first review the information for authors — abstract submission guidelines.


Topics & Application Areas

  • Cancer Diagnostics
  • Cancer Biomarkers
  • Nanoparticle Platforms
  • Drug Delivery
  • Therapeutic Delivery
  • Cancer Immunotherapeutics
  • Modeling & Simulation
  • Nanomedicine Clinical Trials: Challenges & Results
  • Other
2017 Sponsors & Partners
2017 Sponsors & Partners

TechConnect World 2018

Jointly produced by